These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109 [TBL] [Abstract][Full Text] [Related]
4. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma. Mao L; Wang Y; Wang D; Han G; Fu S; Wang J PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891 [TBL] [Abstract][Full Text] [Related]
5. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone. Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854 [TBL] [Abstract][Full Text] [Related]
6. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma. Van Hees S; Michielsen P; Vanwolleghem T World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734 [TBL] [Abstract][Full Text] [Related]
7. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment. Trojan J; Raedle J; Zeuzem S Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428 [No Abstract] [Full Text] [Related]
9. Commentary on "Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma". Lewis PD Transl Res; 2013 Nov; 162(5):275-8. PubMed ID: 24035850 [No Abstract] [Full Text] [Related]
10. γ-Glutamyl transferase and its role as a biomarker of systemic malignancies other than hepatocellular carcinomas. Kapoor S Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):387. PubMed ID: 23348021 [No Abstract] [Full Text] [Related]
11. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead. Giannini EG; Farinati F; Trevisani F Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475 [No Abstract] [Full Text] [Related]
16. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma. Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109 [TBL] [Abstract][Full Text] [Related]
17. Hope for a cure through earlier detection of hepatocellular cancer. Sitzmann JV Ann Surg Oncol; 1999 Mar; 6(2):133-4. PubMed ID: 10082034 [No Abstract] [Full Text] [Related]
18. [Discovery of novel blood markers for liver diseases]. Ikeda H Rinsho Byori; 2012 Mar; 60(3):218-23. PubMed ID: 22568084 [TBL] [Abstract][Full Text] [Related]
19. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580 [No Abstract] [Full Text] [Related]
20. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]